FRESITA PROTEINS (BSE 519242)₹113.35−3.94%Edible Oil
In the Jun 2026 quarter (standalone), FRESITA PROTEINS reported sales of ₹13.01 Cr, up 18.6% from Jun 2025, and net profit of ₹1.65 Cr. For the year to Mar 2026, sales were ₹16.17 Cr and net profit ₹0.63 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 1.01 | 0.07 | 0.00 | 0.15 | 24.10 | 0.00 | 10.97 | 4.31 | 0.26 | 0.66 | 13.01 |
| Expenses | 0.04 | 1.02 | 0.07 | 0.07 | 0.02 | 23.90 | 0.09 | 11.41 | 4.00 | 0.36 | 0.04 | 16.21 |
| Operating Profit | −0.04 | −0.02 | −0.01 | −0.07 | 0.10 | 0.09 | −0.09 | −0.48 | 0.28 | −0.11 | 0.59 | −3.26 |
| OPM % | — | −3.0% | −33.3% | — | 78.6% | 0.4% | — | −4.5% | 6.7% | −48.0% | 92.3% | −25.2% |
| Other Income | 0.03 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.23 | 5.46 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.00 | 0.00 | 0.01 | −0.07 | 0.10 | 0.09 | −0.09 | −0.48 | 0.39 | −0.11 | 0.83 | 2.20 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 20.1% | 0.0% | 0.0% | 0.0% | 0.0% | 25.0% |
| Net Profit | 0.00 | 0.00 | 0.01 | −0.07 | 0.10 | 0.09 | −0.10 | −0.48 | 0.39 | −0.11 | 0.83 | 1.65 |
| EPS (Rs) | −0.05 | 0.05 | 0.11 | −0.45 | 0.63 | 0.57 | −0.63 | −2.83 | 2.31 | −0.69 | 0.93 | 1.84 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.07 | 6.19 | 5.66 | 7.23 | 5.41 | 11.37 | 10.78 | 5.81 | 1.31 | 24.23 | 16.17 | 18.24 |
| Expenses | 2.17 | 6.34 | 5.99 | 7.32 | 5.30 | 11.35 | 10.48 | 5.94 | 1.44 | 24.10 | 15.83 | 20.61 |
| Operating Profit | −0.11 | −0.16 | −0.34 | −0.10 | 0.08 | −0.01 | 0.25 | −0.14 | −0.14 | 0.01 | 0.28 | −2.50 |
| OPM % | −5.8% | −2.7% | −6.2% | −1.5% | 1.7% | −0.2% | 2.4% | −2.6% | −11.6% | 0.1% | 1.8% | −13.7% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.02 | 0.07 | 0.07 | 0.08 | 0.15 | 0.16 | 0.00 | 0.34 | 5.79 |
| Interest | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.03 | 0.02 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −0.16 | −0.18 | −0.36 | −0.08 | 0.16 | 0.05 | 0.34 | 0.00 | 0.01 | 0.01 | 0.63 | 3.31 |
| Tax % | −5.8% | −31.5% | −10.8% | 44.5% | 82.4% | 133.4% | 14.4% | 500.1% | 0.0% | 100.1% | 0.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −0.14 | −0.12 | −0.32 | −0.11 | 0.02 | −0.01 | 0.30 | −0.02 | 0.01 | 0.00 | 0.63 | 2.76 |
| EPS (Rs) | −0.86 | −0.74 | −1.90 | −0.69 | 0.16 | −0.11 | 1.79 | −0.16 | 0.11 | 0.05 | 0.70 | 4.39 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.43 | 2.50 | 2.49 | 2.51 | 2.51 | 2.51 | 2.51 | 2.51 | 2.50 | 2.50 | 2.50 | 2.51 |
| Reserves | 0.30 | 0.15 | 0.02 | −0.32 | −0.45 | −0.42 | −0.44 | −0.13 | −0.16 | −0.14 | −0.14 | 0.52 |
| Borrowings | 0.21 | 0.61 | 0.20 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 |
| Other Liabilities | 0.19 | 0.20 | 0.20 | 0.12 | 0.11 | 0.06 | 0.07 | 0.06 | 0.05 | 0.07 | 0.28 | 83.35 |
| Total Liabilities | 3.13 | 3.46 | 2.91 | 2.31 | 2.19 | 2.15 | 2.14 | 2.44 | 2.39 | 2.43 | 2.64 | 86.55 |
| Fixed Assets | 0.11 | 0.07 | 0.06 | 0.04 | 0.03 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 3.02 | 3.39 | 2.85 | 2.27 | 2.16 | 2.13 | 2.12 | 2.44 | 2.39 | 2.43 | 2.64 | 86.55 |
| Inventories | 0.00 | 2.01 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Trade receivables | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 3.98 |
| Cash & equivalents | 0.99 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.98 |
| Total Assets | 3.13 | 3.46 | 2.91 | 2.31 | 2.19 | 2.15 | 2.14 | 2.44 | 2.39 | 2.43 | 2.64 | 86.55 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.71 | −1.19 | −0.08 | 0.47 | −0.58 | −0.04 | −0.04 | 0.09 | −0.29 | −0.22 | −0.10 | −76.30 |
| Cash from investing activity | 1.91 | 0.21 | 0.00 | 0.03 | 0.12 | 0.10 | 0.09 | 0.10 | 0.17 | 0.18 | 0.00 | 0.37 |
| Cash from financing activity | −0.12 | 0.36 | −0.41 | −0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 83.40 |
| Net cash flow | 1.06 | −0.64 | −0.52 | 0.31 | −0.48 | 0.04 | 0.04 | 0.20 | −0.15 | −0.08 | −0.09 | 7.49 |
| Capex | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free cash flow | 0.74 | −1.19 | −0.10 | 0.49 | −0.60 | −0.05 | −0.06 | 0.11 | −0.31 | −0.24 | −0.12 | −76.59 |
| CFO / OP % | 525.1% | 1,000.1% | 53.1% | −133.9% | 536.1% | −21.9% | 200.1% | 38.1% | 200.1% | 153.1% | −549.9% | −26,340.9% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 15 | 0 | 40 | 46 | 37 | 57 | 26 | 8 | 0 | 0 | 0 | 97 |
| Inventory days | 32 | 323 | 63 | 28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days payable | 1 | 0 | 1 | 0 | — | — | — | — | — | — | — | — |
| Cash conversion cycle | 45 | 323 | 102 | 72 | 35 | 55 | 24 | 6 | 0 | 0 | 0 | 95 |
| Working capital days | 66 | 253 | 109 | 77 | 85 | 116 | 57 | 65 | 131 | 605 | 35 | −103 |
| ROCE % | −5.9% | −4.5% | −6.0% | −14.6% | −5.6% | 8.2% | 2.9% | 15.8% | 0.4% | 0.9% | 0.8% | 23.1% |
For the Jun 2026 quarter, FRESITA PROTEINS reported sales of ₹13.01 Cr, up 18.6% year on year and net profit of ₹1.65 Cr. The operating margin was −25.2%.
FRESITA PROTEINS' sales for the year to Mar 2026 were ₹16.17 Cr; over the last twelve months they were ₹18.24 Cr.
Net profit for the year to Mar 2026 was ₹0.63 Cr, and ₹2.76 Cr over the last twelve months. Earnings per share over the same trailing period were ₹4.39.
FRESITA PROTEINS reported borrowings of ₹0.17 Cr at Mar 2026, against cash and equivalents of ₹7.98 Cr.
Cash from operations was −₹76.30 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹76.59 Cr.